Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Emerging global scholars from Africa

Dr Salum Lidenge - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Emerging global scholars from Africa ( Dr Salum Lidenge - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
9 Mar 2023

Choosing Wisely in educating future African oncologists

Dr Nazima Dharsee - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in educating future African oncologists ( Dr Nazima Dharsee - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
9 Mar 2023

Navigating evidence-based care with limited resources in Africa

Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana
Navigating evidence-based care with limited resources in Africa ( Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana )
9 Mar 2023

Choosing Wisely in surgical oncology

Prof Larry Akoko - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
Choosing Wisely in surgical oncology ( Prof Larry Akoko - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania )
8 Mar 2023

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
8 Mar 2023

Childhood cancer: the surprising scientific facts

Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia
Childhood cancer: the surprising scientific facts ( Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia )
7 Mar 2023

Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer

Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023

SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy

Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023

IORT at University Hospital Augsburg in Germany

Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany
IORT at University Hospital Augsburg in Germany ( Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany )
3 Mar 2023

IORT at Fortis Hospital Bangalore in India

Dr Sandeep Nayak - Fortis Hospital, Bangalore, India
IORT at Fortis Hospital Bangalore in India ( Dr Sandeep Nayak - Fortis Hospital, Bangalore, India )
3 Mar 2023

Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region

Dr Ibtihal Fadhil - Eastern mediterranean NCD Alliance, Kuwait City, Kuwait
Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region ( Dr Ibtihal Fadhil - Eastern mediterranean NCD Alliance, Kuwait City, Kuwait )
2 Mar 2023

Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy ( Prof Andrea Necchi -  The Vita-Salute San Raffaele University, Milan, Italy )
23 Feb 2023